Regucalcin transgenic (TG) rat has been generated to determine a role of endogenous regucalcin in metabolic disorders. Regucalcin TG rats induced a prominent increase in regucalcin protein in the various tissues. Bone loss and hyperlipidemia were found to induce in regucalcin TG rats with growing and aging. Bone loss induced in regucalcin TG rats was resulted from enhanced osteoclastogenesis and suppressed osteoblastic mineralization in rat marrow cells. Moreover, hyperlipidemia induced in regucalcin TG rats was seen with increasing age; serum triglyceride, high-density lipoprotein (HDL)-cholesterol, free fatty acid, albumin and calcium concentrations were markedly increased in regucalcin TG. Decrease in lipid and glycogen contents in the liver tissues was also induced in regucalcin TG rats. The gene expression of leptin and adiponectin was suppressed in the adipose and liver tissues of TG rats. Regucalcin possessed insulin resistance in liver cells. Regucalcin revealed stimulatory effects on adipogenesis that is differentiated from messenchymal stem cells to adipocytes in bone marrow cells. Regucalcin may be implicated to obesity and diabetes associated with osteoporosis. Regucalcin TG rat model may be a useful tool in the development of therapeutic tools for metabolic disorder associated with osteoporosis in vivo.
Read full abstract